Election Results Could Translate to Increased Scrutiny for FDA

Congressional oversight of the FDA is likely to increase dramatically following Republican gains in Tuesday’s election. Scott Gottlieb, a resident fellow at the American Enterprise Institute and former FDA deputy commissioner, said the House Energy and Commerce Committee is likely to hold hearings concentrating on the FDA’s performance and the impact its focus on risk aversion is having on the consistency and performance of the review process.
Devices & Diagnostics Letter